The White House revealed that US President Donald Trump is being treated with an experimental antibody cocktail for Corona virus developed by a company Regeneron President Trump’s doctor, Dr. Sean Conley, wrote in the White House memo, “After confirming the president’s diagnosis of coronavirus, as a precaution, he received a single 8-gram dose of Regeneron.”
According to the Daily Mail, Dr. Conley added that Trump was taking zinc, vitamin D, famotidine (the generic name for Pepcid AC), melatonin and daily aspirin.
Regeneron cocktail contains, RAIN-COV2, On an antibody made by the company from mice and another isolated from a Covid 19 patient who recovered, and each of them may help neutralize the Corona virus.
It shows the most recent data Regeneron From ongoing experiments, the drug has reduced viral loads for patients who have not been admitted to hospital and reduced recovery times by nearly half, but it is largely an experimental treatment, and the data announced earlier this week is the first to be published from the trial.
Two patients treated with the antibody cocktail had unwanted side effects, one of which was a “serious” adverse reaction, but Regeneron He did not disclose the details of what happened to the patient, who received a low dose of the drug.
–
Peter Horby, professor of emerging diseases at Oxford University, told the Today On BBC radio, the drug is safe and just one treatment can provide protection for up to six weeks, before it is added again.
He explained, “It is a synthetic antibody, a mixture of two antibodies, designed to bind strongly to a protein on the surface of the virus. This helps prevent the virus from attaching to cells, entering them and reproducing, and it helps our immune system to attack and kill the virus.”
“This class of drugs has existed for a long time and is widely used in cases of infections and cancers and is very safe … This specific drug may have been given to around 400 patients with mild or severe symptoms in various trials and so far there are no worrisome safety signals,” he added.
He continued, saying: “The drug is promising and very strong, and it has shown positive results in the laboratory, as it had a very strong effect against the virus, and there were some studies on artificially infected animals as it also showed benefits, so the available drugs are one of the most promising drugs.”
“It is antiviral, so it works in patients whose virus is still multiplying, so it can be used at any stage of the disease and for any age group,” he added.
–
– .
